Latest News and Press Releases

Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Cancer Vaccines Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global cancer vaccine...

BASEL, Switzerland – 4th October 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, announces...

Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccines Market Report by Type,, Technology, Indication, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...

Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Vaccines...

BASEL, Switzerland – 17th July 2024 - Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector-based cancer vaccines targeting neoantigens, today...

Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global mRNA Cancer Vaccines Clinical Trials & Market Future Outlook 2024" drug pipelines has been added to ResearchAndMarkets.com's...

Dr. Gallagher, current President of R&D at Syndax Pharmaceuticals and former Chief Medical Officer and Head of Development at AbbVie, brings significant experience of end-to-end development that...

Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...

Pune, India, Dec. 19, 2023 (GLOBE NEWSWIRE) -- The size of the global cancer vaccines market is anticipated to increase at a CAGR of 14.7% throughout the forecast period, from USD 7.32 billion in...

Dublin, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global...